Share
- Release Date: 05/07/12 17:11
- Summary: NTA: MLN: MLN NAV $0.8835 as at 3/7/12
- Price Sensitive: No
- Download Document 1.79KB
MLN
05/07/2012 15:11
NTA
REL: 1511 HRS Marlin Global Limited
NTA: MLN: MLN NAV $0.8835 as at 3/7/12
MLN NAV $0.8835 as at 3/7/12
Date 3/7/2012 30/6/2012
MLN NAV $0.8835 $0.8765
Share price close $0.73 $0.70
Discount 17% 20%
The above NAV is unaudited.
The net asset value per share is after deducting treasury stock (shares
acquired under the Marlin Global buyback programme).
The five largest portfolio holdings at 3 July 2012 are approximately as
follows:
Biotest (Germany) 6%
Sarin Technologies (Israel) 5%
Orthofix (United States) 4%
Stratec Biomedical (Germany) 4%
Horiba (Japan) 4%
One of Marlin Global's investments, Fook Woo Group Limited ("Fook Woo"), has
voluntarily suspended its trading on the Hong
Kong stock exchange since 28 November 2011. The value of Marlin Global's
holding in Fook Woo has been written down by 40%.
Fook Woo comprises 2% of the portfolio as at the date of this NAV
announcement.
BACKGROUND
Marlin Global Limited ("Marlin Global") is a listed investment company that
invests in companies based outside of New Zealand and Australia. The
investment portfolio of Marlin Global is managed by Fisher Funds Management
Limited, a specialist fund manager with a track record of successful
investing. Marlin Global aims to offer investors competitive returns and
access to a diversified portfolio of investments through a single, tax
efficient investment vehicle. Marlin Global may invest in listed
international growth companies on any approved stock exchange (excluding New
Zealand or Australia) or unlisted international companies not incorporated in
New Zealand or Australia. The company listed on the New Zealand Exchange in
November 2007.
For further information please contact Marlin Global Limited, ph (09) 484
0365.
End CA:00224682 For:MLN Type:NTA Time:2012-07-05 15:11:18
